Skip to main content
Caplight Logo









Picterus AS

Picterus AS

Private
TrondheimHealthcare & Life Scienceshttps://picterus.com/

Last Round

Grant

Jan 28, 2026

Total Funding Raised

$3.15M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Picterus AS is a medical technology company that develops smartphone-based screening tools for neonatal jaundice.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Telemedicine, Computer Vision

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

neonatal jaundicejaundice screeningnon-invasive monitoringdigital healthremote patient monitoringRPMmedical AIcomputer visionsmartphone diagnosticsmHealthtelemedicinepoint of carePOCusage-based SaaSneonatal care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Picterus AS Comparables

Compare Picterus AS with similar companies based on industry and business-model similarity.

Picterus AS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shenzhen Beishen Healthcare Technology Co., Ltd.
77%
Delta Medical International Ltd
72%
Bilimetrix S.r.l.
68%

Picterus AS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 28, 2026
GrantMar 1, 2020
AngelMay 24, 2017
GrantDec 15, 2015

Key People

Founding team and executive leadership

Sarah Rose Jones

CEO Picterus Newborn Health

Executive Team

Tormod Thomsen

CEO, Chairman

Executive Team

Christian Larsen Temte

CFO

Executive Team

Picterus AS Investors

Notable investors and investment history

Picterus AS investors
InvestorRounds
Eurostars SME programmeGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2026

    Monthly visitors increased 3230% MoM, reaching 4.8K.

  • Feb 12, 2026

    Grew 19% QoQ, from 21 to 25 employees.

Picterus AS Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Picterus AS Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Picterus AS's valuation, stock price, and market status.

Firmographic Details

HeadquartersTrondheim
Employee Range25
Year Founded2015
Last FundingJan 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?